• GAPNA 2020 National President Deborah Dunn, EdD, MSN, GNP-BC, ACNS-BC, GS-C interviews Dr. Ron Billano Ordona, DNP, FNP-BC about providing home-based primary care during COVID 19.

    "Facing Forward: Providing Home-based Primary Care during COVID 19"


    View the Video

  • GAPNA 40th AnniversaryGAPNA’s anniversary theme “Preserve the Past, Enhance the Present, and Secure the Future,” reflects our shared vision for gerontological advanced practice nursing.

     

    Learn How You Can Help

  • GAPNA Exchange

       

    GAPNA Exchange is a private, secure community for members to share ideas, ask questions, lend expertise, and network with peers.

    It features both an Open Forum discussion area along with smaller, segmented communities.

    Interact with GAPNA members wherever and whenever!

    Go to GAPNA Exchange

  • CoronaCoronavirus (COVID-19) Resources

    In an effort to support our members with the most updated information on COVID-19 we developed this resource page to easily access current CDC information and other resources to assist you professionally and personally.

    We will continue to update this page with more information as it becomes available and welcome your input as we navigate through this situation. As health care professionals it is our job to educate our patients and families on prevention and the what to do if someone is symptomatic.

    View resources

     

Radiation Therapy Linked to Dry Mouth in Elderly Patients with Head and Neck Cancers

Head and neck cancer may be treated by a combination of radiation therapy (RT) and chemotherapy, in addition to surgery.

A common side effect associated with RT for tumors arising in the head and neck region is xerostomia (dry mouth), a potentially serious post-treatment complication that can affect speech, chewing, and swallowing, and lead to gum infections, cavities, and loss of teeth.

New research shows elderly patients receiving RT either with or without chemotherapy had a higher cumulative incidence of developing xerostomia than those who had neither RT nor chemotherapy.

The risk of xerostomia was regardless of tumor stage at presentation, anatomic primary tumor site, and whether primary cancer treatment included surgery. It was higher in some subgroups of patients, namely in women with distant stage disease or in those with poorly differentiated localized tumors.

The risk of xerostomia was lower in patients 80 years or older with the anatomic tumor site at the salivary gland.

For details, see Liu, C-C. et al. (2011). Risk of xerostomia in association with the receipt of radiation therapy in older patients with head and neck cancer. American Journal of Therapeutics, 18, 206-215.

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: